Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Merck & Co., Inc. | 149,553.9 | reported | 24 Feb 2014 | tx 37+1,620,749−217,597 |
| CELGENE CORP /DE/ | 20,285 | reported | 30 Jul 2018 | tx 48+565,561−125,883 |
| BIOGEN INC. | 18,966.11 | reported | 20 Mar 2007 | tx 21+246,984−74,139.02 |
| METABOLIX, INC. | 10,000 | reported | 22 May 2019 | tx 23+309,806 |
| ALNYLAM PHARMACEUTICALS, INC. | 1,446 | reported | 20 May 2026 | tx 6+14,621 |
| MERCK & CO INC | 0 | reported | 03 Nov 2009 | tx 12+440,250−440,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,441 | 0.00 USD | deriv |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 775 | 0.00 USD | |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,558 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 5,228 | 0.00 USD | deriv |
| 07 Mar 2023 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4,948 | 0.00 USD | deriv |
| 22 May 2019 | GRANT_AWARD | METABOLIX, INC. | 10,000 | 0.00 USD | deriv |
| 31 Dec 2018 | GRANT_AWARD | METABOLIX, INC. | 6,128 | 0.76 USD | deriv |
| 28 Sept 2018 | GRANT_AWARD | METABOLIX, INC. | 3,512 | 1.33 USD | deriv |
| 30 Jul 2018 | GRANT_AWARD | CELGENE CORP /DE/ | 20,285 | 0.00 USD | deriv |
| 29 Jun 2018 | GRANT_AWARD | METABOLIX, INC. | 3,583 | 1.31 USD | deriv |
| 23 May 2018 | GRANT_AWARD | METABOLIX, INC. | 10,000 | 0.00 USD | deriv |
| 08 May 2018 | GRANT_AWARD | CELGENE CORP /DE/ | 20,285 | — | deriv |
| 08 May 2018 | GRANT_AWARD | CELGENE CORP /DE/ | 10,301 | — | deriv |
| 04 May 2018 | EXERCISE | CELGENE CORP /DE/ | 3,500 | 0.00 USD | |
| 04 May 2018 | TAX_WITHHOLDING | CELGENE CORP /DE/ | 1,622 | 86.89 USD | |
| 04 May 2018 | EXERCISE | CELGENE CORP /DE/ | 3,500 | 0.00 USD | deriv |
| 29 Mar 2018 | GRANT_AWARD | METABOLIX, INC. | 2,958 | 1.58 USD | deriv |
| 17 Feb 2018 | EXERCISE | CELGENE CORP /DE/ | 7,283 | 0.00 USD | |
| 17 Feb 2018 | TAX_WITHHOLDING | CELGENE CORP /DE/ | 2,329 | 95.26 USD | |
| 17 Feb 2018 | EXERCISE | CELGENE CORP /DE/ | 7,283 | 0.00 USD | deriv |
| 13 Feb 2018 | GRANT_AWARD | CELGENE CORP /DE/ | 7,283 | 0.00 USD | deriv |
| 29 Jan 2018 | GRANT_AWARD | CELGENE CORP /DE/ | 13,377 | 0.00 USD | deriv |
| 29 Dec 2017 | GRANT_AWARD | METABOLIX, INC. | 6,726 | 1.39 USD | deriv |
| 19 Dec 2017 | EXERCISE | CELGENE CORP /DE/ | 3,410 | 0.00 USD |